Literature DB >> 17210448

Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.

Naoki Fujita1, Shinichiro Horiike, Ryosuke Sugimoto, Hideaki Tanaka, Motoh Iwasa, Yoshinao Kobayashi, Koji Hasegawa, Ning Ma, Shosuke Kawanishi, Yukihiko Adachi, Masahiko Kaito.   

Abstract

Hepatic oxidative stress occurs in chronic hepatitis C (CH-C), but little is known about its producing mechanisms and precise role in the pathogenesis of the disease. To determine the relevance of hepatic oxidatively generated DNA damage in CH-C, 8-hydroxy-2'-deoxyguanosine (8-OHdG) adducts were quantified in liver biopsy specimens by immunohistochemical staining, and its relationship with clinical, biochemical, and histological parameters, and treatment response was assessed in 40 CH-C patients. Hepatic 8-OHdG counts were significantly correlated with serum transaminase levels (r=0.560, p=0.0005) and histological grading activity (p=0.0013). Remarkably, 8-OHdG levels were also significantly related to body and hepatic iron storage markers (vs serum ferritin, r=0.565, p=0.0004; vs hepatic total iron score, r=0.403, p=0.0119; vs hepatic hepcidin messenger RNA, r=0.516, p=0.0013). Baseline hepatic oxidative stress was more prominent in nonsustained virological responder (non-SVR) than in SVR to interferon (IFN)/ribavirin treatment (50.8 vs 32.7 cells/10(5) microm2, p=0.0086). After phlebotomy, hepatic 8-OHdG levels were significantly reduced from 53.4 to 21.1 cells/10(5) microm2 (p=0.0125) with concomitant reductions of serum transaminase and iron-related markers in CH-C patients. In conclusion, this study showed that hepatic oxidatively generated DNA damage frequently occurs and is strongly associated with increased iron deposition and hepatic inflammation in CH-C patients, suggesting that iron overload is an important mediator of hepatic oxidative stress and disease progression in chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17210448     DOI: 10.1016/j.freeradbiomed.2006.11.001

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  34 in total

1.  Identification of treatment efficacy-related host factors in chronic hepatitis C by ProteinChip serum analysis.

Authors:  Naoki Fujita; Mamoru Nakanishi; Jun Mukai; Yuuji Naito; Takafumi Ichida; Masahiko Kaito; Toshikazu Yoshikawa; Yoshiyuki Takei
Journal:  Mol Med       Date:  2010-10-05       Impact factor: 6.354

Review 2.  DNA damage response and sphingolipid signaling in liver diseases.

Authors:  Masayuki Nagahashi; Yasunobu Matsuda; Kazuki Moro; Junko Tsuchida; Daiki Soma; Yuki Hirose; Takashi Kobayashi; Shin-Ichi Kosugi; Kazuaki Takabe; Masaaki Komatsu; Toshifumi Wakai
Journal:  Surg Today       Date:  2015-10-29       Impact factor: 2.549

3.  Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C.

Authors:  Jerzy Jaroszewicz; Magdalena Rogalska; Iwona Flisiak; Robert Flisiak
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

4.  8-Hydroxy-2'-deoxyguanosine expression predicts hepatocellular carcinoma outcome.

Authors:  Shengmian Li; Xiaoling Wang; Yijuan Wu; Huijing Zhang; Lan Zhang; Cuiju Wang; Ruixing Zhang; Zhanjun Guo
Journal:  Oncol Lett       Date:  2011-11-10       Impact factor: 2.967

5.  Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis C.

Authors:  Takashi Himoto; Hirohito Yoneyama; Akihiro Deguch; Kazutaka Kurokohchi; Michio Inukai; Hisashi Masugata; Fuminori Goda; Shoichi Senda; Seishiro Watanabe; Satoru Kubota; Shigeki Kuriyama; Tsutomu Masaki
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

Review 6.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

7.  A modified alkaline comet assay for measuring DNA repair capacity in human populations.

Authors:  Andrzej R Trzeciak; Janice Barnes; Michele K Evans
Journal:  Radiat Res       Date:  2008-01       Impact factor: 2.841

8.  Decreased mitochondrial deoxyribonucleic acid and increased oxidative damage in chronic hepatitis C.

Authors:  Hsu-Heng Yen; Kai-Lun Shih; Ta-Tsung Lin; Wei-Wen Su; Maw-Soan Soon; Chin-San Liu
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

9.  Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C.

Authors:  Naoki Fujita; Yoshiyuki Takei
Journal:  J Gastroenterol       Date:  2007-11       Impact factor: 7.527

10.  Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: relevance to hepatitis C.

Authors:  Swati Joshi-Barve; Kiranmayi Amancherla; Madhuvanti Patil; Aruni Bhatnagar; Stephanie Mathews; Leila Gobejishvili; Matthew Cave; Craig McClain; Shirish Barve
Journal:  Free Radic Biol Med       Date:  2009-04-01       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.